comprehensive -WSS

comprehensive

author：knowledge 2025-08-24 23:26:16 - browse：35

Methadone and buprenorphine, both FDA-approved drugs, are considered the gold standard for treating opioid use disorder. They are so effective, in fact, that they are considered nearly curative for people who use them as prescribed. But a multitude of social and physical barriers to access mean that only about 20% of people who could benefit from these medicines have access to them. Access is even harder for pregnant people, who face additional stigmas and challenges.

Arthur Robin Williams, an addiction psychiatrist, and Judith Cole, a nurse practitioner, join the podcast this week to speak about the challenges during pregnancy, including the reality that federal law makes it possible for child protective services to be called when people receiving legal effective treatments for addiction give birth. Despite medications like methadone being fully safe during pregnancy, they continue to carry a stigma that can result in trauma for both birth parents and newborns.

“What’s getting conflated here is a result on a drug test, for instance, with actual abuse or neglect,” said Williams.

Williams and Cole wrote about this issue in their recent First Opinion essay, “Mothers in treatment for opioid use disorder shouldn’t also have to fight child protective services.” You can read more about barriers to addiction treatment in STAT reporter Lev Facher’s series “The War on Recovery.”

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts. And don’t forget to sign up for the First Opinion newsletter to read each week’s best First Opinion essays.

Previous article： Hollywood unions extend contract negotiations for actors
Next article： HIV vaccine remains elusive. Immunologists keep trying new ideas

WSS

Nick Leschly quits Bluebird Bio spinout amid restructuring, layoffs

Arc Institute generative AI designs new CRISPR systems

Readers respond to H5N1 and livestock movements, and more

Long Covid needs a new name — and a new frame

PEPFAR is under serious threat — and so is global health

Readout Newsletter: Nvidia, Biogen, Ionis, AstraZeneca, ChatGPT

knowledge

comprehensive

knowledge

Virginia high school admissions case could be legal follow

How to make the FDA’s new prescription one

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Analysis of pharma R&D ranks Novo Nordisk, J&J above their peers

At least 13 dead in Texas as scorching temps continue

How housing is health care on Long Island

Hepatitis C has a cure — but many Americans still lack access to it

Military medical care influenced by rank and race, new study finds

Medical leaders decry Supreme Court decision on affirmative action

FDA approves updated Covid vaccines

entertainment

Telehealth for opioid use disorder is lifesaving

It's time to retire 'poor historian' from clinicians' vocabularies

Food makers to regulators: Ultra

Anxious about a speech? A startup wants you to pop a minty cardiac drug

Regeneron agrees to White House price limits on anti

Readout LOUD podcast: Live from STAT Breakthrough Summit West

knowledge

knowledge

focus

knowledge